KDM1A and small cell lung carcinoma: In the both human SCLC cell lines and immunocompetent mouse models, LSD1 inhibition restored surface MHC-I, transcriptionally activated antigen-presentation genes, and engaged interferon signaling, rendering SCLC cells susceptible to MHC-I-restricted T cell cytolysis (176).